St. Jude Announces Upbeat Trial Results
St. Jude Medical Inc. (NYSE: STJ) announced that its advanced atrial fibrillation treatment for a heart rhythm disorder was more effective than medication. The stock price soared $3.06 to close at $40.56.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.